• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ROCHE CARDIAC D-DIMER; FIBRINOGEN AND FIBRIN SPLIT PRODUCTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ROCHE CARDIAC D-DIMER; FIBRINOGEN AND FIBRIN SPLIT PRODUCTS Back to Search Results
Catalog Number 04877802190
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/17/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).This event occurred in (b)(6).
 
Event Description
The customer received questionable d-dimer results for five patient samples from a cobas h232 meter serial number (b)(4) on (b)(6) 2017 when compared to the results previously obtained from a mini vidas analyzer.The cobas h232 meter is not sold nor is like or similar to a product sold in the united states.It was unclear if the same samples were used for the testing on the different devices.Clarification was requested but was not provided.Sample 1: the result from the mini vidas on (b)(6) 2017 was 198.93 ng/ml.The result from the h232 meter was 180.00 ng/ml.Sample 2: the result from the mini vidas on (b)(6)2017 was 2119.51 ng/ml.The result from the h232 meter was 490.0 ng/ml.Sample 3: the result from the mini vidas on (b)(6) 2017 was 853.30 ng/ml.The result from the h232 meter was 550.00 ng/ml.Sample 4: the result from the mini vidas on (b)(6) 2017 was 1130.25 ng/ml.The result from the h232 meter was 680 ng/ml.Sample 5: the result from the mini vidas on (b)(6) 2017 was 324.98 ng/ml.The result from the h232 meter was 280.0 ng/ml.The erroneous results were not reported outside of the laboratory.The patients were not adversely affected.No customer material was received for investigation.Relevant retention material of roche cardiac d-dimer of lot 19752510 was tested on a qualified cobas h232 with: two native blood samples and two spiked blood samples (c=0.80 ¿g/ml and c=1.10 ¿g/ml), each blood sample was tested with three test strips.The mean of the measurements on a qualified cobas h232: first native blood sample: 0.17 ug/ml.Second native blood sample: 0.29 ug/ml.First spiked blood sample (c=0.80 ¿g/ml): 0.76 ug/ml.Second spiked blood sample (c=1.10 ¿g/ml): 0.99 ug/ml.The results of all measurements fulfill the requirements.
 
Manufacturer Narrative
A specific root cause could not be identified.Based on the available information, there was no indication of a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROCHE CARDIAC D-DIMER
Type of Device
FIBRINOGEN AND FIBRIN SPLIT PRODUCTS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key6893088
MDR Text Key89504622
Report Number1823260-2017-02088
Device Sequence Number1
Product Code GHH
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K033491
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 10/09/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/01/2017
Device Catalogue Number04877802190
Device Lot Number19752510
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/01/2017
Initial Date FDA Received09/26/2017
Supplement Dates Manufacturer Received09/01/2017
Supplement Dates FDA Received10/09/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-